Parallel Advisors »

Abcellera Biologics shares owned by Parallel Advisors

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $14k 2.5k 5.71
2023-09-30 $2.5k 538 4.60
2023-06-30 $2.7k 424 6.46
2023-03-31 $2.3k 301 7.54
2022-12-31 $1.8k 179 10.13

More positions owned by Parallel Advisors

Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Ishares S&p 500 Index Etf (IVV)
Apple Stock (AAPL)
Corcept Therapeutics Stock (CORT)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Microsoft Stock (MSFT)
Cvb Finl Corp Stock (CVBF)
Nvidia Corp Stock (NVDA)
Ishares Core Msci Eafe Etf Etf (IEFA)
Vanguard Large Cap Etf (VV)
Amazon.com Stock (AMZN)
Ishares Tr Lehman Short Trea Bd Etf (SHV)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Ishares Aggregate Bond Etf Etf (AGG)
Vanguard Small Cap Etf Etf (VB)

View all positions for Parallel Advisors

Top funds holding Abcellera Biologics

Baillie Gifford & Co
Baker Bros. Advisors
Credit Suisse
OrbiMed Advisors
Arrowpoint Asset Management
Founders Fund VII Management
Lazard Asset Management
Federated Investors
Casdin Capital
Guardian Capital Advisors
Millennium Management
Two Sigma Investments
Citadel Advisors
Two Sigma Advisers
Norges Bank Investment Management

View all funds holding Abcellera Biologics